CNBX PHARMACEUTICALS INC. (CNBX) Net margin 2016–2024
CNBX PHARMACEUTICALS INC. (CNBX) net profit margin by fiscal year — reported net income divided by reported revenue.
-534.5%FY2024 · since FY2016: -273.0% → -534.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -534.5% | +370.1 pp |
| FY2023 | -904.6% | +11523.7 pp |
| FY2022 | -12428.2% | — |
| FY2020 | -104337.9% | -115848.3 pp |
| FY2019 | 11510.4% | +50846.1 pp |
| FY2018 | -39335.7% | -5313.1 pp |
| FY2017 | -34022.5% | -33749.5 pp |
| FY2016 | -273.0% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice